Amgen, Astellas Pay $125 Million to Settle Federal Kickback Allegations

Drug Industry Daily
A A
Amgen and Astellas Pharma have agreed to pay nearly $125 million to settle federal allegations that they exploited charities to protect the prices of their favored drugs.

To View This Article:

Login

Subscribe To Drug Industry Daily